Volume 133, Issue 4, Pages (October 2007)

Slides:



Advertisements
Similar presentations
Volume 115, Issue 4, Pages (October 1998)
Advertisements

Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Volume 136, Issue 1, Pages (January 2009)
Reduced Graft-versus-Host Disease in C3-Deficient Mice Is Associated with Decreased Donor Th1/Th17 Differentiation  Qing Ma, Dan Li, Roza Nurieva, Rebecca.
Volume 17, Issue 5, Pages (November 2002)
Volume 134, Issue 7, Pages (June 2008)
Volume 131, Issue 5, Pages (November 2006)
Volume 25, Issue 2, Pages (August 2006)
CD44 Deficiency Attenuates Chronic Murine Ileitis
Volume 140, Issue 1, Pages e2 (January 2011)
Volume 137, Issue 4, Pages e3 (October 2009)
Volume 143, Issue 5, Pages (November 2012)
Exacerbated colitis associated with elevated levels of activated CD4+ T cells in TCRα chain transgenic mice  Immo Prinz, Uwe Klemm, Stefan H.E. Kaufmann,
Volume 136, Issue 1, Pages (January 2009)
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 136, Issue 3, Pages (March 2009)
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 133, Issue 1, Pages (July 2007)
Volume 141, Issue 2, Pages e4 (August 2011)
Lung Natural Helper Cells Are a Critical Source of Th2 Cell-Type Cytokines in Protease Allergen-Induced Airway Inflammation  Timotheus Y.F. Halim, Ramona H.
Volume 134, Issue 2, Pages (February 2008)
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Volume 10, Issue 1, Pages (January 2015)
Volume 122, Issue 1, Pages (January 2002)
Volume 42, Issue 5, Pages (May 2015)
Volume 137, Issue 5, Pages e1 (November 2009)
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 132, Issue 7, Pages (June 2007)
Volume 126, Issue 4, Pages (April 2004)
Volume 137, Issue 4, Pages (October 2009)
Volume 128, Issue 5, Pages (May 2005)
Volume 136, Issue 2, Pages (February 2009)
Volume 28, Issue 4, Pages (April 2008)
Volume 130, Issue 2, Pages (February 2006)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 35, Issue 1, Pages (July 2011)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 143, Issue 3, Pages e2 (September 2012)
Volume 132, Issue 5, Pages (May 2007)
Volume 143, Issue 1, Pages (July 2012)
Volume 137, Issue 4, Pages e3 (October 2009)
Volume 142, Issue 4, Pages e2 (April 2012)
Volume 134, Issue 7, Pages (June 2008)
Volume 138, Issue 2, Pages (February 2010)
Volume 132, Issue 1, Pages (January 2007)
Volume 120, Issue 4, Pages (March 2001)
Volume 129, Issue 3, Pages (September 2005)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 135, Issue 4, Pages (October 2008)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 135, Issue 5, Pages e5 (November 2008)
Volume 135, Issue 2, Pages e2 (August 2008)
A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses  Guangxun Meng, Fuping Zhang, Ivan Fuss,
Volume 33, Issue 5, Pages (November 2010)
Volume 137, Issue 4, Pages (October 2009)
Volume 142, Issue 5, Pages (May 2012)
Volume 16, Issue 2, Pages (February 2002)
Volume 33, Issue 4, Pages (October 2010)
Volume 41, Issue 4, Pages (October 2014)
Volume 127, Issue 5, Pages (November 2004)
Volume 32, Issue 5, Pages (May 2010)
Volume 38, Issue 3, Pages (March 2013)
Volume 140, Issue 1, Pages (January 2011)
Volume 131, Issue 5, Pages (November 2006)
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 28, Issue 5, Pages (May 2008)
Volume 136, Issue 7, Pages (June 2009)
Volume 131, Issue 6, Pages (December 2006)
Volume 25, Issue 3, Pages (September 2006)
Presentation transcript:

Volume 133, Issue 4, Pages 1188-1197 (October 2007) Lymphocyte-Dependent and Th2 Cytokine-Associated Colitis in Mice Deficient in Wiskott-Aldrich Syndrome Protein  Deanna D. Nguyen, Michel H. Maillard, Vinicius Cotta–de–Almeida, Emiko Mizoguchi, Christoph Klein, Ivan Fuss, Cathryn Nagler, Atsushi Mizoguchi, Atul K. Bhan, Scott B. Snapper  Gastroenterology  Volume 133, Issue 4, Pages 1188-1197 (October 2007) DOI: 10.1053/j.gastro.2007.07.010 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 A majority of WKO mice develop spontaneous colitis and splenomegaly. (A) Upper left panel shows normal WT (top) compared with thickened WKO (bottom) mouse colons. H&E staining reveals crypt elongation and a large inflammatory cell infiltrate into the lamina propria of WKO mouse colon (right, objective: ×10) compared with normal WT mouse colon (lower left, objective: ×10). Splenomegaly is often associated with colitis in WKO mice (upper middle panel). Bar represents 1 cm. Prevalence of (B) clinical (weight loss, diarrhea, rectal prolapse, or death) and (C) microscopic (wall thickening, LP infiltration, crypt abscess) signs of colitis by age. Note that none of the 11 WT mice followed concurrently demonstrated any clinical or histologic signs of colitis. Gastroenterology 2007 133, 1188-1197DOI: (10.1053/j.gastro.2007.07.010) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 WKO colonic LP is infiltrated with several distinct leukocyte subsets. Note an increase of macrophages (F4/80+ cells, black arrowheads), CD8+ cells (black arrows), and dendritic cells (CD11c+ cells, black curved arrows) in WKO colonic lamina propria. Data are representative of stainings of 2–4 WT and WKO samples each. Staining was performed on WKO colons with severe colitis (age, >6 months). All micrographs were taken with ×10 objective. Gastroenterology 2007 133, 1188-1197DOI: (10.1053/j.gastro.2007.07.010) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 WKO mouse colonic LP contains activated T cells. Lymphocytes from WT and WKO mice colonic lamina propria (LP), mesenteric lymph nodes (MLN), subcutaneous lymph nodes (SLN), and spleen (SPL) were analyzed for activation markers. WKO mouse LP is composed of a higher percentage of T cells (ie, TCRβ+) than WT mice. There is marked expansion of activated T cells (as evidenced by CD69+ and CD62L− staining) in the LP and less striking expansion in other lymphoid compartments in WKO mice compared with WT mice. Data are representative examples of at least 3 individual experiments. Mice used in the experiment were 3–4 months of age. Numbers represent percentages of cells within the lymphocyte gate that stain positive. Gastroenterology 2007 133, 1188-1197DOI: (10.1053/j.gastro.2007.07.010) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 WKO mouse lymphocytes are required and CD4+ T cells are sufficient for colitis induction. (A) Representative cross sections of colons from WKO or WT mouse bone marrow cells (BMC) → RAG-2 KO transfer recipients (objective: ×4). Note the absence of colitis in recipients that received only WT mouse BMCs compared with the markedly thickened colon of recipients of WKO mouse BMCs. (B) WRDKO mice do not develop colitis (objective: ×4). (C) Macroscopic (upper panels) and microscopic analyses (lower panels, objective: ×10) demonstrated that CD4+ T cells from WKO (right) but not WT mice (center) can transfer colitis to RAG-2 KO recipients. Representative colon from RAG-2 KO control mice colons is shown on the left. Gastroenterology 2007 133, 1188-1197DOI: (10.1053/j.gastro.2007.07.010) Copyright © 2007 AGA Institute Terms and Conditions

Figure 5 Relative Th2 skewing associated with colitis in WKO mice. (A) WKO mouse LP cells secrete markedly elevated levels of IL-4 and IL-13 as well as IFN-γ, TNF-α, and IL-2 with a decrease in IL-6. Results shown are means ± SEM pooling from 3 to 4 experiments, *P < .05 between WT and WKO cells stimulated with P+I. (B) Only IL-4 and IL-10 are mildly elevated in WKO mouse MLN compared with WT mice. Results shown are means ± SEM pooling from 3 to 4 experiments, *P < .05 between WT and WKO cells stimulated with P+I. (C) Shown are representative sections of 2 independent experiments of WT (left panel, objective: ×10) and inflamed (5-month-old) WKO (right panel, objective: ×10; inset, objective: ×40) mouse colonic sections stained for IL-4 by immunohistochemistry. US, unstimulated; P+I, stimulated with phorbol myristate acetate (PMA) and ionomycin. Gastroenterology 2007 133, 1188-1197DOI: (10.1053/j.gastro.2007.07.010) Copyright © 2007 AGA Institute Terms and Conditions

Figure 6 Neutralization of IFN-γ does not alleviate colitis in WKO mice. (A) Mice treated with weekly injections of anti-IFN-γ antibody (n = 7), but not mice treated with control IgG antibodies (n = 11), lost weight. (B) Average histologic scores of anti-IFN-γ Ab-treated mice compared with control IgG Ab-treated mice 1 week after final antibody treatment (P = .07). Gastroenterology 2007 133, 1188-1197DOI: (10.1053/j.gastro.2007.07.010) Copyright © 2007 AGA Institute Terms and Conditions

Figure 7 Neutralization of IL-4 attenuates WKO mouse colitis. (A) Mice treated with weekly injections of anti-IL-4 Ab, but not mice treated with control IgG antibodies, gained weight. (B) Representative sections from mice treated with anti-IL-4 Ab and mice treated with control IgG antibodies that developed colitis (objective: ×10). (C) LP cells from mice treated with anti-IL-4 Ab secreted negligible amounts of cytokines. In contrast, LP cells from mice treated with control rat IgG antibodies that developed severe colitis secreted a moderate amount of IL-10 and a large amount of IL-4, IL-13, and IFN-γ, *P < .05 between cells stimulated with P+I from mice treated with anti-IL-4 Ab and mice treated with control IgG antibodies that developed colitis. Shown are means ± SEM pooling from 2 to 4 mice in each group. US, unstimulated; P+I, stimulated with PMA and ionomycin. (D) WASP/IL-4 DKO mice demonstrated higher weights and lower clinical colitis scores at 18 weeks of age than WKO counterparts that were followed concurrently, P < .05. Gastroenterology 2007 133, 1188-1197DOI: (10.1053/j.gastro.2007.07.010) Copyright © 2007 AGA Institute Terms and Conditions

Figure 8 CD4+ T cells from WKO mice can be skewed to secrete Th1 or Th2 cytokines. (A) Representative flow cytometry plots of intracellular IL-4 and IFN-γ staining in WT (n = 3) and WKO (n = 3) CD4+ T cells polarized to Th0, Th1, or Th2 by appropriate stimulations. (B) Graphs representing the mean percentages ± SD of CD4+ T cells expressing IL-4 or IFN-γ in cells isolated from WT (n = 3) and WKO (n = 3) mice polarized in Th0, Th1, or Th2 conditions. Gastroenterology 2007 133, 1188-1197DOI: (10.1053/j.gastro.2007.07.010) Copyright © 2007 AGA Institute Terms and Conditions